Heartflow

Heartflow company information, Employees & Contact Information

Explore related pages

Related company profiles:

Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRCT Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. With over 400,000 patients treated, more than 1,400 leading institutions adopting our solution, and 99.5% of U.S. lives covered — Heartflow is redefining the standard of coronary care. We're a global company, with employees across the United States, Europe and Japan. Our headquarters are in Mountain View, California, with additional offices in California, Texas, the UK and Japan. We believe CAD shouldn’t be a silent threat. We’re changing the story of CAD by making it screenable, diagnosable, and manageable — empowering clinicians to save lives and giving patients more time for what matters most.

Company Details

Employees
709
Address
331 E Evelyn Ave, Mountain View,california 94041,united States
Phone
650-241-1221
Email
in****@****low.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Mountain View, California
Looking for a particular Heartflow employee's phone or email?

Heartflow Questions

News

Heartflow (Nasdaq: HTFL) sets third quarter results and call for Nov. 12 at 4:30 p.m. ET - Stock Titan

Heartflow (Nasdaq: HTFL) sets third quarter results and call for Nov. 12 at 4:30 p.m. ET Stock Titan

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning - GlobeNewswire

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning GlobeNewswire

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025 - 富途牛牛

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025 富途牛牛

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - Yahoo Finance

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform Yahoo Finance

Heartflow to Present DECIDE Data at SCCT 2025 - Diagnostic and Interventional Cardiology

Heartflow to Present DECIDE Data at SCCT 2025 Diagnostic and Interventional Cardiology

Heartflow (NASDAQ: HTFL) unveils PCI Navigator for 3D planning; NAVIGATE-PCI enroll 2,500 - Stock Titan

Heartflow (NASDAQ: HTFL) unveils PCI Navigator for 3D planning; NAVIGATE-PCI enroll 2,500 Stock Titan

Heartflow Rebrands, Reaffirms Commitment to Improving CAD Care Management - Diagnostic and Interventional Cardiology

Heartflow Rebrands, Reaffirms Commitment to Improving CAD Care Management Diagnostic and Interventional Cardiology

95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan

95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval Stock Titan

NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With - GlobeNewswire

NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With GlobeNewswire

AI Healthcare Pioneer Heartflow Raises Massive $364M in Upsized IPO with Strong Investor Demand - Stock Titan

AI Healthcare Pioneer Heartflow Raises Massive $364M in Upsized IPO with Strong Investor Demand Stock Titan

HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis - Diagnostic and Interventional Cardiology

HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis Diagnostic and Interventional Cardiology

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients - Diagnostic and Interventional Cardiology

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients Diagnostic and Interventional Cardiology

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease - Diagnostic and Interventional Cardiology

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease Diagnostic and Interventional Cardiology

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study - Diagnostic and Interventional Cardiology

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study Diagnostic and Interventional Cardiology

Study Confirms Positive Long-Term Outcomes Using AI-enabled FFRCT and Plaque Analysis - Diagnostic and Interventional Cardiology

Study Confirms Positive Long-Term Outcomes Using AI-enabled FFRCT and Plaque Analysis Diagnostic and Interventional Cardiology

HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting - Diagnostic and Interventional Cardiology

HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting Diagnostic and Interventional Cardiology

SCCT 2024: HeartFlow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography - Diagnostic and Interventional Cardiology

SCCT 2024: HeartFlow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography Diagnostic and Interventional Cardiology

Heartflow Introduces PCI Planning Tool - Diagnostic and Interventional Cardiology

Heartflow Introduces PCI Planning Tool Diagnostic and Interventional Cardiology

HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage - Diagnostic and Interventional Cardiology

HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage Diagnostic and Interventional Cardiology

TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights - Diagnostic and Interventional Cardiology

TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights Diagnostic and Interventional Cardiology

HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease - Diagnostic and Interventional Cardiology

HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease Diagnostic and Interventional Cardiology

HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT - Diagnostic and Interventional Cardiology

HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT Diagnostic and Interventional Cardiology

New HeartFlow RoadMap Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings - Diagnostic and Interventional Cardiology

New HeartFlow RoadMap Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings Diagnostic and Interventional Cardiology

HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap Analysis - Diagnostic and Interventional Cardiology

HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap Analysis Diagnostic and Interventional Cardiology

HeartFlow Announces CEO Transition - Diagnostic and Interventional Cardiology

HeartFlow Announces CEO Transition Diagnostic and Interventional Cardiology

HeartFlow Files for FDA Review to Evaluate the Coronary Occlusions and Plaque - Diagnostic and Interventional Cardiology

HeartFlow Files for FDA Review to Evaluate the Coronary Occlusions and Plaque Diagnostic and Interventional Cardiology

New Plaque Clinical Data Provides Additional Insights on Anatomy and Physiology in Clinical Decision Making for Patients - Diagnostic and Interventional Cardiology

New Plaque Clinical Data Provides Additional Insights on Anatomy and Physiology in Clinical Decision Making for Patients Diagnostic and Interventional Cardiology

Philips and HeartFlow announce global collaboration agreement - Philips

Philips and HeartFlow announce global collaboration agreement Philips

HeartFlow Appoints Timothy Barabe to its Board - citybiz

HeartFlow Appoints Timothy Barabe to its Board citybiz

HeartFlow Appoints John Farquhar as Chief Operating Officer - citybiz

HeartFlow Appoints John Farquhar as Chief Operating Officer citybiz

New Policy Decisions Give Millions Access to HeartFlow FFRct Analysis - Diagnostic and Interventional Cardiology

New Policy Decisions Give Millions Access to HeartFlow FFRct Analysis Diagnostic and Interventional Cardiology

HeartFlow Enters into Licensing Agreement with Cedars-Sinai for Coronary Plaque Assessment Technology - Imaging Technology News

HeartFlow Enters into Licensing Agreement with Cedars-Sinai for Coronary Plaque Assessment Technology Imaging Technology News

UH Case Medical Center First to Offer Novel HeartFlow CT-FFR Technology - Imaging Technology News

UH Case Medical Center First to Offer Novel HeartFlow CT-FFR Technology Imaging Technology News

CT-FFR Changes Treatment Plan for More Than One-Third of Coronary Artery Disease Patients - Imaging Technology News

CT-FFR Changes Treatment Plan for More Than One-Third of Coronary Artery Disease Patients Imaging Technology News

Top Heartflow Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant